Tonira Pharma Ltd(merged)
- Market Cap ₹ Cr.
- Current Price ₹ 19.8
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 2.08 %
- ROE -15.4 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2010 | Mar 2011 | |
|---|---|---|
| 36.81 | 30.04 | |
| 29.97 | 26.31 | |
| Operating Profit | 6.84 | 3.73 |
| OPM % | 18.58% | 12.42% |
| 0.23 | 0.28 | |
| Interest | 2.88 | 3.14 |
| Depreciation | 2.84 | 3.07 |
| Profit before tax | 1.35 | -2.20 |
| Tax % | 24.44% | -5.45% |
| 1.02 | -2.08 | |
| EPS in Rs | ||
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -300% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2010 | Mar 2011 | |
|---|---|---|
| Equity Capital | 7.94 | 7.94 |
| Reserves | 6.31 | 4.23 |
| 31.29 | 36.73 | |
| 8.06 | 6.63 | |
| Total Liabilities | 53.60 | 55.53 |
| 24.72 | 23.56 | |
| CWIP | 0.54 | 1.22 |
| Investments | 0.04 | 0.03 |
| 28.30 | 30.72 | |
| Total Assets | 53.60 | 55.53 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2010 | Mar 2011 | |
|---|---|---|
| -0.94 | ||
| -2.63 | ||
| 2.71 | ||
| Net Cash Flow | -0.86 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2010 | Mar 2011 | |
|---|---|---|
| Debtor Days | 62.77 | 46.29 |
| Inventory Days | 233.19 | 359.23 |
| Days Payable | 129.62 | 118.43 |
| Cash Conversion Cycle | 166.34 | 287.09 |
| Working Capital Days | 162.92 | 255.16 |
| ROCE % | 2.08% |
Documents
Announcements
No data available.